In Vivo Pharmacodynamic Evaluation of 4T1 Cells Induced Breast Cancer Models (CAT#: STEM-AE-0657-LGZ)

Introduction

Cancer type: Breast cancer<br />Cell line: 4T1<br />Clone: WT<br />Inoculation: Orthotopic

Principle Applications Procedure Materials Notes Related Products

Principle

By seeding tumor cells at organ-specific sites of the original tumor, in situ models simulate the initial lesion and establish better tumor, stroma, and immune component interactions than subcutaneous implants.

Applications

Breast Cancer

Procedure

1. Disease model construction.
2. Mice dosing.
3. Efficacy monitoring.
4. Biochemical detection of tissue samples.

Materials

• Sample Type: liquid or powder

Other recommended products

In Vivo Pharmacodynamic Evaluation of B-hCD44 Mice (Immune Checkpoint Humanized Mice) (CAT#: STEM-AE-0309-LGZ)
In Vivo Pharmacodynamic Evaluation of B-hCAIX Mice (Humanized Mice) (CAT#: STEM-AE-0596-LGZ)
In Vivo Pharmacodynamic Evaluation of B-hCD32B Mice (Immune Checkpoint Humanized Mice) (CAT#: STEM-AE-0239-LGZ)
In Vivo Pharmacodynamic Evaluation of Hela Cell Line Based Cervical Cancer (CAT#: STEM-AE-0028-LGZ)
In Vivo Pharmacodynamic Evaluation of B-hCD3E/hGPRC5D Mice (Humanized Mice) (CAT#: STEM-AE-0613-LGZ)
In Vivo Pharmacodynamic Evaluation of Type II collagen Induced Arthritis (CIA) in Lewis Rats (CAT#: STEM-AE-0121-LGZ)
In Vivo Pharmacodynamic Evaluation of B-hLTA/hTNFA/hLTB Mice (Cytokine Humanized Mice) (CAT#: STEM-AE-0536-LGZ)
In Vivo Pharmacodynamic Evaluation of CAL27 Cell Line Based Pancreas Cancer (CAT#: STEM-AE-0103-LGZ)